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Abstract
Fentanyl-induced cough is not an uncommon condition during the induction of general anesthesia. A preliminary
randomized controlled study was designed to observe the effects of different priming doses of propofol on fentanyl-induced
cough during anesthesia induction. A total of 120 patients were randomized into 4 groups (n = 30) to receive the intravenous
injection of intralipid (group I), propofol 1 mgkg
-1 (group II), propofol 1.5 mgkg
-1 (group III), or propofol 2 mgkg
-1
(group IV) 1 minute before a bolus of fentanyl 2.5 mgkg
-1. The occurrence and severity of cough were recorded for 2 minutes
after fentanyl bolus. The severity of cough was graded as none (grade 0), mild (grade 1–2), moderate (grade 3–4), or severe
(grade 5 or more). The average bolus time of fentanyl was 1.5 ± 0.3 seconds in the present study. The incidence of fentanyl-
induced cough was 80.0% in group I, 40.0% in group II, 6.7% in group III, and 3.3% in group IV, respectively. Groups II, III,
and IV had a lower incidence and less severity of cough than group I (P < 0.05). Groups III and IV had a lower incidence and
less severity of cough than group II (P < 0.05). In summary, a priming dose of more than 1 mgkg
-1 of propofol is effective
to suppress fentanyl-induced cough in a dose-dependent manner. We suggest using a priming dose of propofol 1.5 mgkg
-1 to
suppress cough during the anesthesia induction with propofol and fentanyl in clinical practice.
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Introduction
Intravenous administration of fentanyl is widely used
during the induction of general anesthesia. Fentanyl-
induced cough is widely reported (1–4) but has not
been considered as a serious anesthetic complication
during anesthesia induction. Lin and colleagues (1)
have shown a 65% incidence of cough in patients
following intravenous administration of fentanyl
2.5 mgkg
-1 via a freely running peripheral venous
catheter within 2 seconds. Böhrer and co-workers
(2) have observed 45.9% of the patients cough after
receiving fentanyl 7 mgkg
-1 through a central venous
catheter, while only 2.7% of the patients cough after
a bolus of fentanyl 7 mgkg
-1 via a peripheral cannula.
Phua and co-authors (3) have demonstrated that the
injection of fentanyl 1.5 mgkg
-1 via a peripheral
venous line elicits cough in 28% of the patients,
and a similar incidence of cough (33%) is documen-
ted by Shen and co-researchers (4) following a bolus
of fentanyl 2 mgkg
-1 via a peripheral venous route
within 5 seconds. The discrepancies in the incidence
of cough among these studies may be attributed to the
different doses, routes, and rates of fentanyl admin-
istration (1–4).
However, fentanyl-induced cough is not always
benign and is undesirable in patients with some
pre-existing diseases, including cerebral aneurysm,
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aortic aneurysm, pneumothorax, and hypersensitive
airway disease (5). Various attempts have been made
to reduce the incidence of fentanyl-induced cough
during anesthesia induction (1,5–8). The primary
effective drugs for suppressing this cough include
lidocaine, ephedrine, b2-receptor agonist, ketamine,
and clonidine (1,5–7). All these drugs have bronch-
orelaxant effects on airway smooth muscle (1,5–7).
Propofol may also induce bronchodilation (9,10),
therefore we hypothesized that an appropriate dose
of propofol might suppress fentanyl-induced cough.
So, we designed a preliminary randomized controlled
study to observe the effects of different priming doses
of propofol on fentanyl-induced cough during anes-
thesia induction.
Materials and methods
Patient population
The Ethics Committee of Afﬁliated Suzhou Hospital
of Nanjing Medical University approved the proto-
col of the present study, and informed written con-
sents were obtained from all patients.
A total of 120 patients of either sex, aged 25
to 60 years, American Society of Anesthesiologists
(ASA) class I or II, scheduled for elective abdominal
surgery with general anesthesia were enrolled in the
present study. Exclusion criteria included: body-
weight exceeding 20% of ideal body-weight (on the
basis of body mass index recommended); impaired
kidney or liver function; presence of a gastric tube; or
a history of asthma, chronic cough, smoking, upper
respiratory tract infection in the previous 2 weeks, or
treated with angiotensin-converting enzyme inhibitors,
bronchodilators, or steroids in the previous 2 weeks.
Dr Tang decided whether a patient should be
included in the present study according to the inclu-
sion and exclusion criteria, randomized the patients
to 4 groups of 30 patients by using a computer-
generated table of random numbers, and was respon-
sible for drug preparation. The allocation sequences
were contained in a set of sealed envelopes, and
the observer and all the patients involved in the
present study were blinded.
Anesthesia induction and data collection
Phenobarbital sodium 0.1 g and atropine 0.5 mg
were injected intramuscularly 30 min before anesthe-
sia. In the operating room, venous access to the
median cubital vein was established with an 18-gauge
cannula. The vertical distance between the drip
bottle and the venous access was 1 meter in all
patients. Electrocardiogram, non-invasive blood pres-
sure, and pulse oximeter were applied throughout
the surgery. Patients were left undisturbed for
more than 1 minute. Then, patients received intra-
venously anesthesia induction as the following
sequence of medications: injecting intralipid (placebo)
0.15 mLkg
-1 in group I, propofol (10 mgmL
-1;
AstraZeneca Co., Italy) 1 mgkg
-1 in group II, pro-
pofol 1.5 mgkg
-1 in group III, and propofol 2 mgkg
-1
in group IV; 1 minute later, bolusing fentanyl
(50 mgmL
-1; Renfu Co., Hubei, China) 2.5 mgkg
-1
in all groups; 2 minutes after fentanyl bolus, pushing
propofol 3, 2, 1.5, and 1 mgkg
-1 in groups I, II, III,
and IV, respectively; and then injecting succinyl-
choline 2 mgkg
-1 in all groups. All the bolus time
of fentanyl was controlled, less then 2 seconds, and
was recorded in the present study. One-and-a-half
minutes after anesthesia induction, all patients were
successfully endotracheally intubated, and they
underwent surgery favorably.
An observer, unaware of the type of medications
given to the patients, recorded the occurrence
and severity of cough for 2 minutes after fentanyl
bolus. The severity of cough was graded as none
(grade 0), mild (grade 1–2), moderate (grade 3–4),
or severe (grade 5 or more).
Statistical analysis
Data are expressed as mean ± SD, number, propor-
tion, or percentage. Statistical analysis was performed
by Statistical Product for Social Sciences (SPSS) soft-
ware 13.0. The frequencies of cough and the propor-
tions of sex and ASA class were compared using
chi-square test or Fisher’s exact test with Bonferroni
correction. One-way analysis of variance was used to
compare the age and weight among the four groups.
P < 0.05 was considered statistically signiﬁcant.
Results
Demographic characteristics
All patients completed the present study. There
was no statistically signiﬁcant difference between
the four groups with regard to age, weight, sex, and
ASA class (P > 0.05, Table I).
Incidence and severity of fentanyl-induced cough
The average bolus time of fentanyl was 1.5 ± 0.3
seconds in the present study. The incidence of
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in group II, 6.7% in group III, and 3.3% in group IV.
Groups II, III, and IV had a lower incidence and less
severity of cough than group I (P < 0.05). Groups III
and IV had a lower incidence and less severity of
cough than group II (P < 0.05). There was no signif-
icant difference in the incidence and severity of cough
between groups III and IV (P > 0.05) (Table II).
Discussion
The major ﬁnding in the present study was that the
pretreatment with propofol 1, 1.5, and 2 mgkg
-1
might reduce fentanyl-induced cough from 80.0%
to 40.0%, 6.7%, and 3.3%, respectively, which was
consistent with our hypothesis.
Various underlying mechanisms of fentanyl-
induced cough have been proposed without deﬁnite
conclusion. Pulmonary chemoreﬂexes mediated by
either vagal C-ﬁber receptors in close proximity to
pulmonary vessels (11,12) or by irritant receptors
have been suggested (2,12). For example, fentanyl
may cause vagal predominance and induce reﬂex
bronchoconstriction and cough (10–13). Effectively
reducing fentanyl-induced cough response from
28% to 6% after aerosol inhalation of salbutamol
(a selective b2-adrenergic bronchodilator) further
supports the mechanism that fentanyl induces cough
via its bronchoconstriction effect (5). In addition,
opioid-induced histamine release (14) and muscle
rigidity leading to sudden adduction of the vocal
cords or supraglottic obstruction (15) are plausible
explanations.
Propofol possesses bronchodilation effect
(9,10,16,17). Burburan and colleagues (16) have
concluded that propofol inhibits bronchoconstriction
and decreases the risk of bronchospasm during anes-
thesia induction. Pizov and co-workers (17) have
shown that the incidence of wheezing was signiﬁcantly
reduced in asthmatic patients receiving a propofol-
based induction of anesthesia compared to a barbi-
turate-based induction. Additionally, propofol has a
signiﬁcant sedative effect that may also reduce the
incidence of cough (7). Therefore, propofol may be a
promising drug to suppress fentanyl-induced cough.
In the present study, we observed that a priming dose
of 1 mgkg
-1 of propofol was able to suppress fentanyl-
induced cough signiﬁcantly and higher doses of
propofol (1.5–2m g kg
-1) were more effective in sup-
pressing fentanyl-induced cough. However, Lin and
colleagues (1) observed that premedication with pro-
pofol 0.6 mgkg
-1 could not inhibit fentanyl-induced
cough signiﬁcantly. So, we presume that propofol
may suppress fentanyl-induced cough in a dose-
dependent manner.
The incidence of fentanyl-induced cough varies over
a wide range of 2.7%–65% and primarily depends on
thedosesoffentanyl injected,theratesofinjection,and
the routes of injection (1–4). In the present study, the
incidenceofcough was 80%. The exact reasonsforthis
higher incidence of cough remained unclear. We attri-
bute this higher incidence to the faster bolus speed of
fentanyl (bolus time: 1.5 ± 0.3 seconds) and possible
bias due to the small sample size included in the
present study. So, fentanyl should not be injected
with such rapidity in clinical practice.
It is interesting that the incidence of cough after
fentanyl administration appears to be higher in
Asians compared to Europeans (1–7,18). For exam-
ple, Schäpermeier and Hopf (18) have observed
that the incidence of cough following intravenous
fentanyl 1.5 mgkg
-1 over 2, 5, or 10 seconds is
between 3% and 6% in European patients; whereas
Phua and co-authors (3) have demonstrated that
injection of the same dose of fentanyl (1.5 mgkg-
1)
elicits cough in 28% of the Asian patients.
There are two major limitations in interpreting the
results of the present study. First, the total dose of
3m g kg
-1 of propofol may be somewhat mildly
overdosed even if the priming doses are commonly
clinically used, and the time interval between prim-
ing and supplementing dose of propofol is relatively
Table I. Demographics in four groups (n = 30).
Demographics Group I Group II Group III Group IV
Age, years 41 ± 64 2 ± 74 3 ± 64 2 ± 5
Weight, kg 54 ± 55 9 ± 85 8 ± 65 7 ± 7
Sex (male/female), n 12/1 11/19 10/20 12/18
ASA class (I/II), n 16/14 18/12 15/15 19/11
Data are expressed as mean ± SD or number (proportion). There
was no signiﬁcant difference with regard to demographics between
the four groups.
ASA = American Society of Anesthesiologists.
Table II. Fentanyl-induced cough and its severity in four groups
(n = 30) given intralipid or different priming doses of propofol.
Cough Group I Group II
a Group III
a,b Group IV
a,b
Incidence 24 (80.0) 12 (40.0) 2 (6.7) 1 (3.3)
Severity
None 6 (20.0) 18 (60.0) 28 (93.3) 29 (96.7)
Mild 15 (50.0) 6 (23.3) 2 (6.7) 1 (3.3)
Moderate 7 (23.3) 4 (13.3) 0 (0) 0 (0)
Severe 2 (6.7) 2 (3.3) 0 (0) 0 (0)
Data are expressed as number (percentage).
a P < 0.05, groups II, III, and IV versus group I.
b P < 0.05, groups III and IV versus group II.
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groups are given the same premedication with phe-
nobarbital sodium 0.1 g and atropine 0.5 mg, dosing
per kg body-weight may be unequally distributed
between groups, thus dosing of these drugs may
be scientiﬁc confounders.
In conclusion, a priming dose of more than
1m g kg
-1 of propofol given 1 minute before fentanyl
is effective to suppress fentanyl-induced cough in a
dose-dependent manner. Higher doses of propofol
(1.5–2m g kg
-1) are more effective in suppressing
fentanyl-induced cough. Considering that higher
doses of propofol are associated with a higher inci-
dence of cardiovascular events, we suggest using a
priming dose of propofol 1.5 mgkg
-1 to suppress
cough during the anesthesia induction with propofol
and fentanyl in clinical practice.
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